Statements (61)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:healthcare_organization
|
| gptkbp:affects |
bile ducts
|
| gptkbp:associated_with |
gptkb:hepatitis_B_virus
gptkb:hepatitis_C_virus cirrhosis |
| gptkbp:clinical_trial |
fatigue
fever cholestasis ongoing research anorexia immunotherapy trials targeted therapy trials pruritus |
| gptkbp:complications |
liver failure
metastasis bile duct obstruction |
| gptkbp:current_use |
gptkb:Company
obesity gallstones |
| gptkbp:demographics |
more common in men
typically diagnosed in older adults |
| gptkbp:end_of_life |
5-year survival rate low
|
| gptkbp:genetic_diversity |
gptkb:physicist
ID H1 mutation |
| gptkbp:healthcare |
gptkb:MRI
CT scan ultrasound |
| https://www.w3.org/2000/01/rdf-schema#label |
cholangio carcinoma
|
| gptkbp:number_of_stages |
TNM classification
staging system used |
| gptkbp:occurs_in |
rare
|
| gptkbp:research_focus |
biomarkers
novel therapies early detection methods |
| gptkbp:risk_factor |
liver fluke infection
primary sclerosing cholangitis |
| gptkbp:screenings |
no standard screening
|
| gptkbp:social_responsibility |
biopsy
imaging tests poor prognosis associated with environmental factors geographic variations in incidence increasing incidence in some regions |
| gptkbp:symptoms |
weight loss
abdominal pain jaundice |
| gptkbp:treatment |
gptkb:hospital
palliative care radiation therapy varies by individual chemotherapy transplantation endoscopic procedures late diagnosis high recurrence rate limited treatment options |
| gptkbp:type |
extrahepatic cholangiocarcinoma
intrahepatic cholangiocarcinoma perihilar cholangiocarcinoma |
| gptkbp:bfsParent |
gptkb:vascular_endothelial_growth_factor
|
| gptkbp:bfsLayer |
5
|